Published online August 1, 2005
PEDIATRICS Vol. 116 No. 2 August 2005, pp. 556-557 (doi:10.1542/peds.2005-0698TT)
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thatayatikom, A.
Right arrow Articles by Liu, A. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thatayatikom, A.
Right arrow Articles by Liu, A. H.
Related Collections
Right arrowRelated AAP Red Book topics:
Respiratory Syncytial Virus
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

SUPPLEMENT ARTICLE

Vascular Endothelial Growth Factor (VEGF) Induces Remodeling and Enhances Th2-Mediated Sensitization and Inflammation in the Lung

Akaluck Thatayatikom, MD

St Louis, MO

Andrew H. Liu, MD

Denver, CO

Lee CG, Link H, Baluk P, et al. Nat Med. 2004;10:1095–1103


   Purpose of the Study.
TOP
 Purpose of the Study.
Study Population.
 Methods.
 Results.
 Conclusions.
 Reviewers' Comments.
 
To evaluate the role of vascular endothelial growth factor (VEGF) in T-helper type 2 (Th2) cell-mediated airway inflammation.


   Study Population.
TOP
 Purpose of the Study.
 Study Population.
Methods.
 Results.
 Conclusions.
 Reviewers' Comments.
 
Lung-targeted VEGF165 transgenic mice and wild-type mice.


   Methods.
TOP
 Purpose of the Study.
 Study Population.
 Methods.
Results.
 Conclusions.
 Reviewers' Comments.
 
Phenotypes of transgenic mice with elevated VEGF induced by doxycycline were studied and compared with wild-type mice. Airway histologic and physiologic assessments with special stains of microvasculatures, epithelium cells, inflammatory cells, smooth muscle cells, and dendritic cells (DCs) as well as allergen sensitization and methacholine tests were performed.


   Results.
TOP
 Purpose of the Study.
 Study Population.
 Methods.
 Results.
Conclusions.
 Reviewers' Comments.
 
Both Th2 and epithelial cells were primary sources of VEGF. Mice with overexpressed VEGF in the airways demonstrated increased neovascularization, mucous gland metaplasia, edema, collagen deposition, myocyte hyperplasia with enlarged smooth muscle bundles, inflammatory cells, activated DCs, airway hyperresponsiveness, interleukin 13 mRNA expression, Th2 responses, and allergen sensitization.


   Conclusions.
TOP
 Purpose of the Study.
 Study Population.
 Methods.
 Results.
 Conclusions.
Reviewers' Comments.
 
VEGF is a potent mediator of allergic airway inflammation by enhancing allergen sensitization, airway hyperresponsiveness, Th2 inflammation, and airway remodeling.


   Reviewers’ Comments.
TOP
 Purpose of the Study.
 Study Population.
 Methods.
 Results.
 Conclusions.
 Reviewers' Comments.
 
Well-described airway pathology in asthma includes epithelial desquamation, goblet cell hyperplasia, collagen deposition below the basement membrane, smooth muscle hypertrophy/hyperplasia, and the growth and proliferation of new blood vessels. Although its pathogenesis is still unclear, VEGF (an inducer of angiogenesis) recently attracted considerable attention as a major contributor to airway remodeling. VEGF was first discovered as a vascular permeability factor >20 years ago. Subsequently, it was revealed to be a potent inducer of endothelial cell activation and growth. Overexpression of VEGF and its receptor in the airways has been demonstrated in stable asthma and during asthma exacerbations and are reduced by conventional asthma therapies (ie, inhaled corticosteroids and leukotriene receptor antagonists). The findings of this study imply an essential role of VEGF in asthma pathogenesis with links to Th2-mediated airway inflammation and remodeling. The results of this study may also inform the link of respiratory syncytial virus infection and asthma development in children, because respiratory syncytial virus up-regulates VEGF production. This disclosed role of VEGF highlights a potential therapeutic role for a VEGF receptor antagonist in asthma.

PEDIATRICS (ISSN 1098-4275). ©2005 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thatayatikom, A.
Right arrow Articles by Liu, A. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thatayatikom, A.
Right arrow Articles by Liu, A. H.
Related Collections
Right arrowRelated AAP Red Book topics:
Respiratory Syncytial Virus
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?